Coherus hires Jim Daly as executive chair of Commercial Advisory Committee.
M2 EQUITYBITES-February 2, 2016-Coherus hires Jim Daly as executive chair of Commercial Advisory Committee
(C)2016 M2 COMMUNICATIONS http://www.m2.com
Biosimilars company Coherus BioSciences (NasdaqGM:CHRS) reported on Monday the addition of Jim Daly as executive chairman of its Commercial Advisory Committee.
In the new role, Daly will be responsible for the company's Commercial Advisory Committee, including overseeing and advising the key strategic commercial issues related to sales, marketing, pricing, contracting, channel strategy development, new product planning and business development.
Most recently, Daly has served as executive vice president and chief commercial officer at Incyte Corporation, from the period 2012 to 2015.
Previously, Daly has worked as senior vice president, North America Commercial Operations, Global Marketing and Commercial Development at fAmgen as well as senior vice president, general manager of the Respiratory and Anti-Infective Division at GlaxoSmithKline.
Currently, Daly is a member of the boards of directors of Chimerix and Acadia Pharmaceuticals.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Feb 2, 2016|
|Previous Article:||Gilead elects Katie Watson as EVP of Human Resources.|
|Next Article:||Gouverneur Bancorp declares 33rd consecutive half yearly dividend of USD0.17 per share.|